Tesamorelin
Peptide Therapy
Starting at $219 per month
Pricing may vary by state.
Key Takeaways — Tesamorelin Peptide Therapy at VitalRx
- Tesamorelin is a prescription-only synthetic GHRH analogue that stimulates pulsatile growth hormone release, shown in a 412-patient JAMA RCT to significantly reduce visceral (abdominal) fat at 26 weeks. [2]
- Not a research chemical. VitalRx tesamorelin is compounded in a federally regulated U.S. pharmacy, shipped cold and constituted, with a verifiable batch Certificate of Analysis.
- Every prescription is physician-reviewed by providers trained under a protocol authored by VitalRx's Board-Certified CMO, licensed in all 50 states.
- How it works: Tesamorelin binds GHRH receptors in the pituitary → triggers pulsatile GH secretion → elevates IGF-1 → promotes lipolysis in visceral adipose tissue.
- Who it is for: Adults with excess visceral fat, suboptimal IGF-1, or metabolic decline who want physician-directed GH support without exogenous HGH.
- Realistic timeline: Measurable metabolic changes from weeks 3–6; body composition changes typically apparent by months 2–4; peak clinical response at 26 weeks.
- Starting at $219/month. Prescription required. Available in all 50 states. 2-day cold shipping included.
✕ Research-only peptides with no medical oversight
✓ Prescription-only. Every order requires physician review and a valid prescription.
✕ Unknown purity, no testing documentation
✓ Compounded in a licensed U.S. pharmacy with a verifiable Certificate of Analysis.
✕ No guidance on dosing, timing, or monitoring
✓ Physician-written protocol with ongoing support and lab guidance.
What Is Tesamorelin Peptide Therapy?
Definition
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) — the peptide your hypothalamus naturally uses to signal your pituitary to produce growth hormone. It is prescribed to stimulate pulsatile GH release, reduce visceral (deep abdominal) fat, and improve metabolic markers. At VitalRx, it is a prescription-only therapy compounded by licensed U.S. pharmacies.
This page is for: Adults researching prescription tesamorelin therapy for visceral fat reduction, body composition, or GH support — and anyone evaluating the difference between medical-grade peptide therapy and research-only peptide sources.
Tesamorelin is one of the most clinically studied peptides used for body composition. It is FDA-approved to reduce visceral adipose tissue (VAT) in adults with HIV-associated lipodystrophy. VAT is the deeper abdominal fat around organs. Higher VAT is linked with insulin resistance, inflammation, dyslipidemia, and increased cardiometabolic risk. [1][2]
Prescription vs. Research Peptides
VitalRx does not sell research chemicals or "for research use only" peptides. All tesamorelin prescriptions are compounded by licensed U.S. pharmacies, prescribed by licensed physicians, and shipped cold with a verifiable Certificate of Analysis.
How Does Tesamorelin Work?
GHRH receptor binding
Tesamorelin binds growth hormone-releasing hormone (GHRH) receptors on pituitary somatotroph cells — the same receptor your hypothalamus naturally signals.
Pulsatile GH secretion
This triggers pulsatile growth hormone release, preserving the body's natural feedback axis. Unlike exogenous HGH, tesamorelin works through your own endocrine system. [2]
IGF-1 elevation
Elevated GH stimulates hepatic production of insulin-like growth factor 1 (IGF-1), which mediates many of GH's downstream metabolic and tissue-repair effects.
Visceral fat mobilization
GH and IGF-1 promote lipolysis preferentially in visceral adipose tissue (VAT). The 412-patient JAMA RCT showed significant VAT reduction vs placebo at 26 weeks. [2]
Lipid & metabolic effects
VAT reduction supports improvements in lipid profiles, insulin sensitivity, and inflammatory markers in some patients. Long-term data shows effects are sustained with continued use and reversible upon discontinuation. [3][5]
How Our Providers Prescribe Tesamorelin
[CMO NAME — update before launch]
Chief Medical Officer — Authored all VitalRx peptide protocols
Board-Certified · Longevity & Anti-Aging Medicine · Licensed in All 50 States
Complete secure intake
Medical history, goals, and current medications reviewed.
Provider evaluation
A licensed physician reviews your intake and determines candidacy.
Lab review (if indicated)
IGF-1, metabolic panel, glucose, and lipid markers may be requested.
Prescription issued
If appropriate, your provider writes the prescription to a licensed U.S. pharmacy.
Pharmacy compounds & ships
Cold-shipped, constituted, with verifiable Certificate of Analysis. 2-day shipping included.
Ongoing monitoring
Provider follow-up, protocol adjustments, and lab guidance as needed.
What Are the Benefits of Tesamorelin?
Visceral fat reduction
- Targets VAT — the metabolically active fat around organs
- 412-patient JAMA RCT: significant VAT reduction at 26 weeks [2]
Body recomposition
- Supports improved fat-to-lean ratio over time
- Helps preserve lean mass during fat-loss phases
Metabolic health support
- VAT reduction supports better insulin sensitivity and lipid profiles [5]
- Some studies show improvements in metabolic markers in studied populations
GH & IGF-1 optimization
- Restores pulsatile GH secretion without exogenous hormone
- IGF-1 elevation supports tissue repair and recovery signaling
Recovery & vitality
- GH and IGF-1 signaling can support recovery pathways
- Patients often pursue tesamorelin alongside training and nutrition plans
Cognitive support (emerging)
- 2012 Arch Neurol RCT: GHRH improved cognition in adults with mild cognitive impairment [4]
- Research is early-stage; not a primary indication
Clinical note: tesamorelin is not an appetite suppressant. Outcomes come from metabolic and body composition shifts, not hunger suppression.
What Results Can You Expect — and When?
Weeks 1–2
- • Protocol initiation. Baseline labs if indicated.
- • Most patients do not notice dramatic changes yet.
Weeks 3–6
- • Early IGF-1 changes measurable in bloodwork.
- • Some patients report improved recovery and energy cues.
Months 2–4
- • Body composition changes become more noticeable.
- • Waist and midsection changes are more common than scale changes.
Month 6 (26 weeks)
- • Peak clinical response in the JAMA RCT. [2]
- • Significant VAT reduction vs placebo at this timepoint.
Months 6+
- • Best outcomes align with consistent dosing, nutrition, and training.
- • Effects sustained with continued use; reversible upon discontinuation. [3]
Your results depend on starting VAT level, sleep, training, nutrition, and adherence. Provider review sets realistic expectations.
Is Tesamorelin Right for You?
Good candidates
- Adults with excess visceral fat despite consistent diet and training
- Patients focused on VAT reduction and metabolic health
- Adults seeking recomposition rather than rapid weight loss
- Patients who want a prescription pathway with medical oversight
Contraindications
- ✕Active malignancy or history of certain cancers (provider evaluates)
- ✕Pregnancy or nursing
- ✕Known hypersensitivity to tesamorelin or mannitol
- ✕Certain pituitary conditions — provider review required
Provider review determines appropriateness. Some patients may need labs or additional screening based on history and risk factors.
How Does Prescription Tesamorelin Compare to Research Peptide Sites?
| Feature | VitalRx (Prescription) | Research Peptide Sites |
|---|---|---|
| Prescription required | Yes — physician-reviewed | No |
| Pharmacy compounded | Licensed U.S. 503A/503B | Unknown source |
| Certificate of Analysis | Verifiable CoA included | Rarely provided |
| Cold-chain shipping | 2-day cold shipping | Often ambient |
| Medical oversight | Licensed physician protocol | None |
| Purity testing | Batch-tested, regulated | Unregulated |
| Intended use | Human use, prescription | "For Research Use Only" |
| Legal status | Legal prescription medication | Gray market |
What Is Tesamorelin Commonly Paired With?
Pairing decisions depend on provider review and your goals.
Ipamorelin + CJC-1295
Paired when sleep quality and recovery signaling are primary goals alongside recomposition. CJC-1295 extends GHRH activity. [6]
NAD+
Paired for mitochondrial health, cellular energy, and anti-aging support alongside GH optimization.
BPC-157
Paired for tissue repair, gut health, and inflammatory modulation alongside body composition therapy.
The VitalRx Tesamorelin Protocol
Our physician-designed protocol uses a graduated dosing approach to ensure safety and optimize results. Patients may choose to stay at any level that is showing results. Any increase in dosage requires physician approval.
Month One — Safety Phase
0.5 mg/day for 30 days
The first month is used to ensure long-term safety. If the patient has no side effects, they may move to month two.
Month Two — Results Phase
1 mg/day for 30 days
This is where real results begin. The body has primed itself in month one, and over month two the patient takes the standard clinical dose.
Month Three — Peak Dose
2 mg/day, Monday–Friday
This is the top dose prescribed. The weekday-only schedule allows for recovery windows while maintaining therapeutic benefit.
Patients may choose to stay at any level that is showing results. Any increase in dosage requires physician approval. Pricing may vary by state.
How Much Does Tesamorelin Therapy Cost?
Starting at $219 per month
Pricing may vary by state.
Prescription required. Provider review required.
Compounded by licensed U.S. pharmacies.
2-day cold shipping included.
Frequently Asked Questions About Tesamorelin
Start Tesamorelin Therapy Online
Complete a secure intake. A licensed provider reviews your information and goals. If appropriate, your prescription is issued and compounded by a licensed U.S. pharmacy. Medication ships to your door with 2-day cold shipping included.
References
- [1] Falutz J, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2349-60. PMID: 18057337.
- [2] Falutz J, et al. Effects of tesamorelin (TH9507), a GHRH analogue, in HIV-infected patients with excess abdominal fat. JAMA. 2010;304(5):509-519. PMID: 20682932.
- [3] Falutz J, et al. Long-term safety and effects of tesamorelin in HIV patients with abdominal fat accumulation. AIDS. 2011;25(11):1433-42. PMID: 21572308.
- [4] Baker LD, et al. Effects of GHRH on cognitive function in adults with mild cognitive impairment. Arch Neurol. 2012;69(11):1420-29. PMID: 22869065.
- [5] Stanley TL, Grinspoon SK. Effects of GHRH on visceral fat, metabolic, and cardiovascular indices. Growth Horm IGF Res. 2015;25(2):59-65. PMID: 25637359.
- [6] Ionescu M, Frohman LA. Pulsatile secretion of GH persists during continuous stimulation by CJC-1295. J Clin Endocrinol Metab. 2006;91(12):4792-97.